117 related articles for article (PubMed ID: 9626455)
1. The expression of drug resistance gene products during the progression of human prostate cancer.
Sullivan GF; Amenta PS; Villanueva JD; Alvarez CJ; Yang JM; Hait WN
Clin Cancer Res; 1998 Jun; 4(6):1393-403. PubMed ID: 9626455
[TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer.
Van Brussel JP; Jan Van Steenbrugge G; Van Krimpen C; Bogdanowicz JF; Van Der Kwast TH; Schröder FH; Mickisch GH
J Urol; 2001 Jan; 165(1):130-5. PubMed ID: 11125381
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
[TBL] [Abstract][Full Text] [Related]
4. [Multidrug resistance mechanisms in cell line HL-60/VCR].
Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
[TBL] [Abstract][Full Text] [Related]
5. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
6. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.
Kim WJ; Kakehi Y; Kinoshita H; Arao S; Fukumoto M; Yoshida O
J Urol; 1996 Aug; 156(2 Pt 1):506-11. PubMed ID: 8683726
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical detection of the p170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: clinical and therapeutical significance.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1311-8. PubMed ID: 9137491
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins.
van Brussel JP; van Steenbrugge GJ; Romijn JC; Schröder FH; Mickisch GH
Eur J Cancer; 1999 Apr; 35(4):664-71. PubMed ID: 10492644
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
12. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells.
Brock I; Hipfner DR; Nielsen BS; Jensen PB; Deeley RG; Cole SP; Sehested M
Cancer Res; 1995 Feb; 55(3):459-62. PubMed ID: 7834606
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer.
Ikeda K; Sakai K; Yamamoto R; Hareyama H; Tsumura N; Watari H; Shimizu M; Minakami H; Sakuragi N
Int J Gynecol Cancer; 2003; 13(6):776-84. PubMed ID: 14675314
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin.
Bader P; Fuchs J; Wenderoth M; von Schweinitz D; Niethammer D; Beck JF
Anticancer Res; 1998; 18(4C):3127-32. PubMed ID: 9713521
[TBL] [Abstract][Full Text] [Related]
16. In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy.
Kasimir-Bauer S; Ottinger H; Meusers P; Beelen DW; Brittinger G; Seeber S; Scheulen ME
Exp Hematol; 1998 Nov; 26(12):1111-7. PubMed ID: 9808049
[TBL] [Abstract][Full Text] [Related]
17. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
[TBL] [Abstract][Full Text] [Related]
18. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.
Chen ZS; Furukawa T; Sumizawa T; Ono K; Ueda K; Seto K; Akiyama SI
Mol Pharmacol; 1999 May; 55(5):921-8. PubMed ID: 10220571
[TBL] [Abstract][Full Text] [Related]
19. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.
Alexander D; Yamamoto T; Kato S; Kasai S
Surg Today; 1999; 29(5):401-6. PubMed ID: 10333409
[TBL] [Abstract][Full Text] [Related]
20. Membrane transport proteins associated with drug resistance expressed in human melanoma.
Schadendorf D; Makki A; Stahr C; van Dyck A; Wanner R; Scheffer GL; Flens MJ; Scheper R; Henz BM
Am J Pathol; 1995 Dec; 147(6):1545-52. PubMed ID: 7495278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
